Performance of a high-intensity 508-gene circulating-tumor DNA (ctDNA) assay in patients with metastatic breast, lung, and prostate cancer.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Pedram Razavi, Bob T. Li, Wassim Abida, Alex Aravanis, Byoungsok Jung, Ronglai Shen, Chenlu Hou, Ino De Bruijn, Sante Gnerre, Raymond S. Lim, Dalicia Reales, Tara Maddala, Michael F. Berger, Gregory J. Riely, Howard I. Scher, William F. Novotny, David B. Solit, Mark Lee, Jorge S. Reis-Filho, Jose Baselga
Institutions: Memorial Sloan Kettering Cancer Center, Grail (United States)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2621656822
